BIOMAT Database Logo BIOMAT Database Logo

Beta-adrenoceptor blockers and the blood-brian barrier. 1981

G Neil-Dwyer, and J Bartlett, and J McAinsh, and J M Cruickshank

1 This study on 21 neurosurgical patients was set up to investigate the extent to which four chronically administered beta-adrenoceptor blockers, propranolol, oxprenolol, metoprolol and atenolol, cross and blood-brain barrier and enter the cerebrospinal fluid (CSF) and brain tissue. The concentration in the CSF of the three lipophilic beta-adrenoceptor blockers, propranolol, oxprenolol and metoprolol, approximated to the free drug concentration in the plasma, and was a poor predictor of brain concentration. These three lipophilic beta-adrenoceptor blockers appeared in brain tissue at concentrations 10-20 times greater than that of hydrophilic atenolol. The approximate brain/plasma ratio for propranolol was 26, for oxprenolol 50, for metoprolol 12 and for atenolol 0.2. 2 The low concentration of atenolol in brain tissue is possibly responsible for the low incidence of central nervous system-related side effects in patients on this agent compared to lipophilic beta-adrenoceptor blockers.

UI MeSH Term Description Entries
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic

Related Publications

G Neil-Dwyer, and J Bartlett, and J McAinsh, and J M Cruickshank
Beta-adrenoceptor blockers and serotonin.
April 2002, British journal of clinical pharmacology,
G Neil-Dwyer, and J Bartlett, and J McAinsh, and J M Cruickshank
beta-adrenoceptor blockers reduce blood pressure in normal subjects.
January 1983, British journal of clinical pharmacology,
G Neil-Dwyer, and J Bartlett, and J McAinsh, and J M Cruickshank
beta-Adrenoceptor blockers and colonic motility.
September 1984, Digestive diseases and sciences,
G Neil-Dwyer, and J Bartlett, and J McAinsh, and J M Cruickshank
The anxiolytic effects of beta-adrenoceptor blockers.
June 1976, Singapore medical journal,
G Neil-Dwyer, and J Bartlett, and J McAinsh, and J M Cruickshank
beta-Adrenoceptor blockers, plasma-potassium, and exercise.
August 1978, Lancet (London, England),
G Neil-Dwyer, and J Bartlett, and J McAinsh, and J M Cruickshank
Beta-adrenoceptor blockers in heart failure.
December 1999, Connecticut medicine,
G Neil-Dwyer, and J Bartlett, and J McAinsh, and J M Cruickshank
Systemic beta-adrenoceptor function and ophthalmic beta-adrenergic blockers.
January 1996, Anesthesia and analgesia,
G Neil-Dwyer, and J Bartlett, and J McAinsh, and J M Cruickshank
beta-Adrenoceptor blockers in the treatment of hypertension.
January 1979, African journal of medicine and medical sciences,
G Neil-Dwyer, and J Bartlett, and J McAinsh, and J M Cruickshank
[beta-Adrenoceptor blockers in the treatment of glaucoma].
July 1979, Ugeskrift for laeger,
G Neil-Dwyer, and J Bartlett, and J McAinsh, and J M Cruickshank
Drug-drug interactions of beta-adrenoceptor blockers.
January 2003, Arzneimittel-Forschung,
Copied contents to your clipboard!